Breaking News - Candlesense

Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LY...

What are the potential upside or downside scenarios if regulatory feedback on LYR-210 is delayed or requires additional studies? How does the Phase 3 success impact the risk profile and discount rate used in DCF models for Lyra Therapeutics? Are there any upcoming catalyst events (e.g., FDA meetings, data releases, partnership announcements) that could drive short‑term stock movement?

Symbol: LYR

Clinical

25 days ago

Read more globenewswire

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights

SOUTH SAN FRANCISCO, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies, to...

Is there any indication of upcoming milestones that could trigger a catalyst-driven price movement? What are the potential risks related to trial enrollment rates and endpoint achievement for the autoimmune programs? How might the Q2 earnings results influence analyst coverage and consensus estimates for NKTX?

Symbol: NKTX

Earnings

25 days ago

Read more globenewswire

Compass Therapeutics Announces Proposed Public Offering

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based...

Symbol: CMPX

Financing

25 days ago

Read more globenewswire

Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025

What risks exist if the proof‑of‑mechanism data does not meet expectations or is delayed? How might the Phase 1 results impact analyst consensus estimates and target price for MZE? What market size and pricing assumptions are being used for PKU and CKD indications?

Symbol: MZE

Earnings

25 days ago

Read more globenewswire

Smart Sand, Inc. Announces Second Quarter 2025 Results

2Q 2025 revenue of $85.8 million 2Q 2025 net income of $21.4 million which includes a $(21.7) million tax benefit 2Q 2025 cash flow used in operations of $(5.1) million 2Q 2025 contribution margin ...

What potential catalysts (e.g., contract wins, operational improvements) could move the stock in the near term? How does Smart Sand's performance stack up against peers in the hydraulic fracturing sand space? What is the company's capital allocation plan—will it address the negative cash flow through debt, equity, or asset sales?

Symbol: SMART

Earnings

25 days ago

Read more prnewswire

Denison Announces Offering of US$250 Million of Convertible Senior Notes

TORONTO, Aug. 12, 2025 /PRNewswire/ - Denison Mines Corp. (TSX: DML) (NYSE AMERICAN: DNN) ("Denison" or the "Company") announces that it is offering convertible senior unsecured notes due 2031 (the...

How might this issuance affect the company’s ESG and sustainability financing metrics? What is the expected impact on the company's dividend policy or share buy‑back plans? How will the offering affect the company’s cash runway and ability to fund exploration projects?

Symbol: DML

Financing

25 days ago

Read more prnewswire

CarParts.com Reports Second Quarter 2025 Results

TORRANCE, Calif., Aug. 12, 2025 /PRNewswire/ -- CarParts.com, Inc. (NASDAQ: PRTS), a leading eCommerce provider of automotive parts and accessories, and a premier destination for vehicle repair and...

How will the Q2 2025 performance impact the technical outlook for PRTS, including key support and resistance levels on the chart? Are there any red‑flag items in the filing (e.g., higher than expected churn, inventory write‑downs, or credit losses) that warrant a risk assessment? What macro or industry trends (e.g., vehicle repair demand, parts supply chain disruptions) are reflected in the results, and how might they influence future quarters?

Symbol: PRTS

Earnings

25 days ago

Read more prnewswire

BNY to Report Third Quarter 2025 Results on October 16, 2025

NEW YORK, Aug. 12, 2025 /PRNewswire/ -- The Bank of New York Mellon Corporation ("BNY") (NYSE: BK), a global financial services company, will report financial results for the third quarter 2025 on ...

Are there any potential surprises or risks (e.g., credit loss provisions, litigation reserves) that could cause volatility after the results are announced? What is the expected market reaction to the earnings release and how should I position ahead of the report? Will the earnings call provide any insight into the bank's strategic initiatives, such as digital transformation or cost‑optimization measures?

Symbol: BK

Earnings

25 days ago

Read more prnewswire